Yes, bioMérieux SA is a publicly traded multinational leader in the in vitro diagnostics industry, with its shares listed on Euronext Paris under the ticker symbol BIM. Headquartered in France, the enterprise designs, develops, and manufactures diagnostic systems used to detect infectious diseases, antimicrobial resistance, and critical pathogens in clinical and industrial applications, offering global institutional and retail investors exposure to the stable healthcare diagnostics sector.